S

Simulations Plus
D

SLP

33.095
USD
0.62
(1.89%)
مغلق
حجم التداول
12,907
الربح لكل سهم
1
العائد الربحي
0.36
P/E
92
حجم السوق
665,575,034
أصول ذات صلة
HIVEUSD
HIVEUSD
0.01374
(5.04%)
0.27254 USD
A
AXS
0.880
(0.88%)
100.580 USD
E
ENJ
-1.270
(-5.95%)
20.080 USD
H
HIVE
-0.04500
(-2.24%)
1.96500 USD
S
SAND
0.23000
(2.70%)
8.75000 USD
المزيد
الأخبار المقالات

العنوان: Simulations Plus

القطاع: Healthcare
الصناعة: Health Information Services
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.